PIPERNO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 16.360
EU - Europa 7.056
AS - Asia 3.499
SA - Sud America 286
AF - Africa 39
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 27.257
Nazione #
US - Stati Uniti d'America 16.080
SG - Singapore 1.287
RU - Federazione Russa 1.278
CN - Cina 1.179
SE - Svezia 1.057
DE - Germania 980
IE - Irlanda 961
UA - Ucraina 841
IT - Italia 766
HK - Hong Kong 649
GB - Regno Unito 371
CA - Canada 265
BR - Brasile 238
FI - Finlandia 218
FR - Francia 146
AT - Austria 143
IN - India 87
VN - Vietnam 74
TR - Turchia 64
NL - Olanda 63
BE - Belgio 62
DK - Danimarca 58
ID - Indonesia 41
BG - Bulgaria 28
JP - Giappone 22
PL - Polonia 14
IR - Iran 13
PK - Pakistan 12
RO - Romania 12
AR - Argentina 11
ZA - Sudafrica 11
KR - Corea 10
CZ - Repubblica Ceca 9
EC - Ecuador 9
LT - Lituania 9
PE - Perù 9
CL - Cile 8
MX - Messico 8
TW - Taiwan 8
AU - Australia 7
CH - Svizzera 6
EG - Egitto 6
EU - Europa 6
IQ - Iraq 6
UZ - Uzbekistan 6
CO - Colombia 5
ES - Italia 5
GR - Grecia 5
MA - Marocco 5
MY - Malesia 5
NO - Norvegia 5
AM - Armenia 4
DO - Repubblica Dominicana 4
KE - Kenya 4
KG - Kirghizistan 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DZ - Algeria 3
MD - Moldavia 3
PH - Filippine 3
SC - Seychelles 3
TH - Thailandia 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 27.257
Città #
Ann Arbor 3.013
Woodbridge 1.748
Fairfield 1.438
Houston 1.327
Chandler 1.026
Dublin 929
Jacksonville 906
Singapore 854
Ashburn 799
Wilmington 746
Hong Kong 641
Frankfurt am Main 629
Seattle 573
Dearborn 565
Cambridge 514
Princeton 361
New York 321
Santa Clara 311
Nanjing 236
Milan 232
Lawrence 174
Shanghai 170
Lachine 155
Altamura 134
Vienna 125
Moscow 107
Beijing 106
San Diego 93
Nanchang 74
Andover 67
Council Bluffs 64
Shenyang 64
Hebei 54
Brussels 52
Guangzhou 49
Los Angeles 49
Dong Ket 47
Toronto 47
Boardman 45
Helsinki 45
Ottawa 44
Jinan 42
Changsha 40
Jiaxing 39
Jakarta 37
Falls Church 35
Tianjin 35
Nuremberg 26
Zhengzhou 26
Dallas 25
London 24
Mountain View 24
Norwalk 24
Belo Horizonte 23
Fremont 23
Ningbo 23
Munich 21
Plovdiv 21
Huizen 19
Rome 19
The Dalles 19
São Paulo 17
Auburn Hills 16
Hefei 16
Kunming 16
Philadelphia 16
Turin 15
Taizhou 14
Chengdu 12
Hangzhou 12
Pune 12
Düsseldorf 11
Kocaeli 11
Lissone 11
Turku 11
Verona 10
Chicago 9
Detroit 9
Edmonton 9
Phoenix 9
Washington 9
Chiswick 8
Kilburn 8
Paris 8
Redmond 8
San Francisco 8
San Mateo 8
Segrate 8
University Park 8
Waanrode 8
Fuzhou 7
Lauterbourg 7
Monmouth Junction 7
Rio de Janeiro 7
Brasília 6
Chongqing 6
Clarks Summit 6
Desio 6
Kiev 6
Lanzhou 6
Totale 19.860
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 457
Hepcidin regulation in a mouse model of acute hypoxia 413
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 320
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 306
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 294
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 276
Juvenile Hemochromatosis 263
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 256
Hif1a: A putative modifier of hemochromatosis 239
Inherited iron overload disorders 235
Hepcidin regulation in a mouse model of acute hypoxia 224
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 217
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 214
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 214
Type 3 hemochromatosis and beta-thalassemia trait 212
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 212
Early impairment of large artery structure and function in Type I diabetes mellitus 211
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 209
Circulating factors are involved in hypoxia-induced hepcidin suppression 206
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 204
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 203
Unexplained isolated hyperferritinemia without iron overload 201
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 200
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 197
Hyperferritinemia and diagnosis of type 1 Gaucher disease 196
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia. 195
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 195
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 193
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 192
Hepatocellular carcinoma in Gaucher disease: an international case series 191
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 183
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 181
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 179
The iron status of Italian subjects with beta-thalassemia trait 179
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 179
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 178
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 178
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 178
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 177
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 176
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 176
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 175
Biochemical and genetic defects underlying human congenital hypotransferrinemia 175
Ferroportin disease: A novel SLC40A1 mutation 175
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 174
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 173
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 172
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 172
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 172
Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload 171
Homozygous deletion of HFE: The Sardinian hemochromatosis? 170
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 169
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 166
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 166
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 165
Different cortical excitability profiles in hereditary brain iron and copper accumulation 165
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 164
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 164
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 164
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 164
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 163
Erythrocyte ferritin in patients on chronic hemodialysis treatment 163
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 162
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 162
Erythrocyte ferritin in thalassemia syndromes 161
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 160
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 159
Increased serum ferritin is common in men with essential hypertension 158
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 158
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 158
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 158
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 157
Myelodysplastic Syndromes and Iron Chelation Therapy 157
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 156
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 156
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 156
Idiopathic haemochromatosis and HLA antigens in Italy: is A3 Bw35 HLA haplotype a marker for idiopathic haemochromatosis gene in north east regions? 154
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 154
Iron overload in subjects with beta-thalassaemia trait: role of idiopathic haemochromatosis gene 153
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 153
Natural history of juvenile haemochromatosis 150
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 150
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 150
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 149
Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F 149
Factors affecting erythrocyte ferritin content in thalassaemia intermedia 148
Haemochromatosis in patients with β-thalassaemia trait 147
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia 147
Ferritin, metabolic syndrome and NAFLD: Elective attractions and dangerous liaisons 145
Idiopathic erythrocytosis: a germline disease? 144
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 144
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (c70r) 143
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 143
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 143
Liver iron influences the response to interferon alpha therapy in chronic hepatitis C 143
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course 141
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 141
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda 141
Homozygosity for transferrin receptor-2 y250x mutation induces early iron overload 140
Novel human pathological mutations. Gene symbol: ALPL. Disease: hypophosphatasia. 140
Totale 18.381
Categoria #
all - tutte 98.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020370 0 0 0 0 0 0 0 0 0 0 295 75
2020/20212.953 233 129 338 327 244 200 265 190 252 361 179 235
2021/20222.444 110 261 325 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20254.610 396 675 231 241 565 176 225 288 740 815 258 0
Totale 28.025